Jaroslaw Leszczyszyn
Founder at Orphinic Scientific SA
Network origin in Jaroslaw Leszczyszyn first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Semiconductors | 6 | |
Orphinic Scientific SA
Orphinic Scientific SA BiotechnologyHealth Technology Orphinic Scientific engages in the development and delivery of pharmaceutical drugs for the treatments of rare diseases. The firm also provides research and development services. The company was founded by and is headquartered in Rome, Italy.
5
| Holding Company | Biotechnology | 5 |
Akademia Medyczna
3
| College/University | Other Consumer Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jaroslaw Leszczyszyn via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
EMC INSTYTUT MEDYCZNY SA | Hospital/Nursing Management | Chairman Corporate Officer/Principal | |
Uniwersytet Ekonomiczny WE Wroclawiu | College/University | Graduate Degree Masters Business Admin | |
Warsaw University of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
Simtop Sp zoo | Director/Board Member | ||
Humboldt-Universität zu Berlin | College/University | Graduate Degree | |
HEWLETT PACKARD ENTERPRISE COMPANY | Computer Processing Hardware | General Counsel | |
ESOTIQ & HENDERSON S.A. | Apparel/Footwear | Director/Board Member | |
Uniwersytet Slaski | College/University | Graduate Degree | |
Amd Tax Sp zoo | Chief Executive Officer | ||
hospitals Projektentwicklungsges mbH
hospitals Projektentwicklungsges mbH Engineering & ConstructionIndustrial Services Part of PORR AG, hospitals Projektentwicklungsges mbH is an Austrian company that specializes in the construction and operation of healthcare facilities. The company is based in Graz, Austria. The CEOs of the company are Stefan Günther, Ludwig Ferdinand Steinbauer. | Engineering & Construction | Director/Board Member | |
Brüggen Polska SP zoo
Brüggen Polska SP zoo Food: Specialty/CandyConsumer Non-Durables Bruggen Polska SP zoo manufacture of grain breakfast food. The firm provides Brüggen brand. It offers organic cornflakes, natural oat, oat honey oat pops, chocolate pops and organic chocolate star products. The company is headquartered in Wilga, Poland. | Food: Specialty/Candy | Director/Board Member | |
University of Wroclaw | College/University | Undergraduate Degree | |
PURE BIOLOGICS S.A. | Biotechnology | Director/Board Member | |
Uniwersytet Przyrodniczy WE Wroclawiu | College/University | Graduate Degree | |
Seal Rock Therapeutics, Inc.
Seal Rock Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Seal Rock Therapeutics, Inc. develops molecule inhibitors apoptosis, inflammation and fibrosis. The company was founded by Kathleen Elias, Neil McDonnell and Artur Plonowski is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder | |
Akademia Wychowania Fizycznego We Wroclawiu | College/University | Undergraduate Degree | |
SYNTHAVERSE S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
Gdanska Fundacja Ksztalcenia Menedzerow | College/University | Masters Business Admin | |
Phase2 Microtechnologies, Inc.
Phase2 Microtechnologies, Inc. Electronic ComponentsElectronic Technology Phase2 Microtechnologies, Inc. is a technology development company that offers Micro-Electro-Mechanical Systems-enabled pH sensor technology platforms. The company was founded in 2016 and is headquartered in Pittsburgh, PA. | Electronic Components | Chairman | |
KCR CRO GmbH
KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Medicover Sp zoo
Medicover Sp zoo Hospital/Nursing ManagementHealth Services Medicover Sp zoo operates healthcare facilities. Its offer includes medical services, surgery, dietary advice, vaccinations, and treatment. The company was founded in 1997 and is headquartered in Warsaw, Poland. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
The World Bank | Supranational | Corporate Officer/Principal | |
Government of Poland | Sovereign | Corporate Officer/Principal | |
Warszawski Uniwersytet Medyczny | College/University | Doctorate Degree | |
Kozminski University | College/University | Masters Business Admin | |
BFF POLSKA SA | Financial Conglomerates | Chairman | |
Fundacja Pomocy Ludziom Przewlekle Chorym Im Henryki Gerber | President | ||
University of Warsaw | College/University | Masters Business Admin | |
Johnson & Johnson Poland Sp zoo
Johnson & Johnson Poland Sp zoo Johnson & Johnson Poland Sp zoo engages in the distribution of medical products. It offers over the counter drugs, surgical sutures, and surgical equipment. Its brands include Ethicon, DePuy Synthes, LifeScan, and Vision Care. The company was founded in 1990 and is headquartered in Warsaw, Poland. | Director/Board Member | ||
EUROSNACK S.A. | Food: Specialty/Candy | Director/Board Member | |
Melita Medical Sp zoo | Corporate Officer/Principal | ||
Biotransplant Research Sp zoo | Corporate Officer/Principal | ||
MARTELA OYJ | Office Equipment/Supplies | Corporate Officer/Principal | |
Vasa Therapeutics, Inc.
Vasa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vasa Therapeutics, Inc. is a private biotechnology company based in Encinitas, CA, committed to discovering and developing transformative therapies for vascular diseases such as heart failure, peripheral artery disease, and sarcopenia. The company's cutting-edge computational chemistry and design platform integrates everything from the identification of viable biological targets to the design and identification of small molecule or peptide therapeutics. Vasa has three active preclinical programs, two small molecule programs focused on the treatment of cardiovascular disease and one peptide therapeutic program aimed at identifying a novel treatment for peripheral artery disease and sarcopenia. The company has a world-class, founder-led team with an outstanding track record of successful development of numerous clinical candidates and commercial drugs spanning multiple therapeutic areas and modalities resulting in several exits values at greater than $1b (USD). The CEO of the company is Mark Robert Herbert. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
Poland | 26 |
United States | 6 |
Germany | 3 |
Austria | 2 |
Finland | 2 |
Sectoral
Consumer Services | 12 |
Health Technology | 5 |
Consumer Non-Durables | 4 |
Health Services | 3 |
Electronic Technology | 3 |
Operational
Director/Board Member | 16 |
Corporate Officer/Principal | 10 |
Undergraduate Degree | 7 |
Chief Executive Officer | 6 |
Founder | 6 |
Most connected contacts
- Stock Market
- Insiders
- Jaroslaw Leszczyszyn
- Company connections